NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan · Delayed Price · Currency is TWD 19.80
0.00 (0.00%)
At close: Mar 24, 2026
TPEX:4732 Market Cap
TPEX:4732 has a market cap or net worth of 930.65 million as of March 24, 2026. Its market cap has decreased by -16.49% in one year.
Market Cap
930.65M
Enterprise Value
391.24M
Revenue
180.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.80
Market Cap Chart
Since December 25, 2007, TPEX:4732's market cap has increased from 285.93M to 930.65M, an increase of 225.49%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 930.65M | -4.58% |
| Dec 31, 2025 | 975.30M | -20.71% |
| Dec 31, 2024 | 1.23B | -8.42% |
| Dec 29, 2023 | 1.34B | -22.70% |
| Dec 30, 2022 | 1.74B | -31.42% |
| Dec 30, 2021 | 2.53B | 109.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 1.25B |
| GeneReach Biotechnology | 1.10B |
| Lukas Biomedical | 1.10B |
| Level Biotechnology | 1.08B |
| Holy Stone Healthcare | 980.95M |
| TCI GENE | 952.51M |
| Taiwan Advance Bio-Pharmaceutical | 931.50M |
| Neith | 899.73M |